Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,512.00    -38.00 (-2.45%)
Bid:
1,510.00
Ask:
1,516.00
Spread: 6.00 (0.397%)
Market Cap: £788.72m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Share Buyback Programme

26 May 2026 14:42

RNS Number : 7554F
M. P. Evans Group PLC
26 May 2026
 

M.P. EVANS GROUP PLC

("Group" or "M.P. Evans")

 

Share buyback programme

The board of directors of M.P. Evans (the "Board") is pleased to announce that the Group is restarting share buybacks by commencing a new programme (the "Programme") with immediate effect.

The Programme will have a budget of up to £2 million to be used to buy back M.P. Evans' shares of 10 pence each ("Shares") in the market over the course of the period from the date of this announcement until the Company's Annual General Meeting, due to take place at 12:00 on Friday 12 June 2026. The Board will consider extending the Programme beyond the AGM, subject to continuing shareholder approval.

The Board believes the Group is well positioned, supported by strong operational cash generation and a robust balance sheet. This provides an opportunity to repurchase Shares at advantageous levels, as part of its overall approach to capital allocation, which will focus on long-term value creation for shareholders.

In order to implement the Programme, M.P. Evans has entered into an agreement with Cavendish Capital Markets Limited ("Cavendish") on the following basis:

· Cavendish will manage the purchases on a discretionary basis, purchasing Shares within certain pre-set parameters and making its trading decisions independently of, and uninfluenced by, the Group. Purchases may therefore continue during any closed periods of the Group.

· The Programme will operate under the authority granted to the Group by shareholders at the Group's most recent Annual General Meeting, held on 13 June 2025.

· Any Shares purchased will be cancelled.

· The Group has authorised the Programme to commence with immediate effect and will continue whilst it retains the authority from shareholders to repurchase Shares until 12 June 2026.

· The Programme will be conducted in accordance with the safe harbour parameters as prescribed by MAR.

26 May 2026

Enquiries:

M.P. Evans Group PLC

Tel: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman

Matthew Coulson, chief executive

Luke Shaw, chief financial officer

Cavendish Capital Markets (Nomad and joint broker)

Tel: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Will Smith, Harriet Ward (ECM)

Canaccord Genuity Limited (Joint broker)

Tel: +44 (0) 20 7523 4500

Henry Fitzgerald-O'Connor, George Grainger

Alma Strategic Communications (Financial PR)

Tel: +44 (0)20 3405 0205

Rebecca Sanders-Hewett, Josh Royston, David Ison

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAFMJTMTJTBLF
Date   Source Headline
19th Mar 20247:00 amRNSFinal Results
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSNotice of Results
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:50 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSPublication of ESG report
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 202410:50 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:30 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSCrop and Production
12th Jan 20247:10 amRNSChange of Adviser
5th Jan 202411:06 amRNSDirector/PDMR Shareholding
2nd Jan 20243:35 pmRNSTotal Voting Rights
2nd Jan 20243:16 pmRNSBlock listing Interim Review
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20239:02 amRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20235:07 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSAcquisition
24th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.